Go to KM Summary
ID Title Status Last Updated Sort ascending
997 Management of DR-TB ADR: Nephrotoxicity [Renal Toxicity] Pending Review 07/04/2022
990 Management of DR-TB ADR: Hematological Abnormalities Pending Review 07/04/2022
998 Management of DR-TB ADR: Gynecomastia Pending Review 07/04/2022
991 Management of DR-TB ADR: Hypothyroidism Pending Review 07/04/2022
992 Management of DR-TB ADR: Arthralgia Pending Review 07/04/2022
993 Management of DR-TB ADR: Depression Pending Review 07/04/2022
994 Management of DR-TB ADR: Psychotic Symptoms Pending Review 07/04/2022
980 Use of Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen in Pre-existing Liver Disease Pending Review 07/04/2022
700 Sustainable Development Goals [SDGs] related to TB Live 04/04/2022
952 Principles of Preparing a realistic ACSM budget Live 27/03/2022
949 ACSM activities at different levels Live 27/03/2022
948 The stages of change model Live 27/03/2022
947 Designing effective messages Live 27/03/2022
946 Communication channels Live 27/03/2022
945 ACSM approaches Live 27/03/2022
944 Developing ACSM objectives Live 27/03/2022
943 ACSM goals for TB Elimination Live 27/03/2022
942 What is SM in ACSM Live 27/03/2022
941 What is C in ACSM Live 27/03/2022
940 What is A in ACSM Live 27/03/2022
955 Patient-provider meetings Live 27/03/2022
953 State TB Forum Live 27/03/2022
954 District TB Forum Live 27/03/2022
571 Importance of Community Engagement in TB Live 27/03/2022
836 Registration of Private Providers and Processing Benefits Live 27/03/2022
833 Roles and responsibilities of Beneficiaries and NTEP Staff to process DBT Live 27/03/2022
832 Incentives for Private Providers and Informants Live 27/03/2022
831 Transport Support for TB Patients in Notified Tribal Areas Live 27/03/2022
830 Nikshay Poshan Yojana Live 27/03/2022
829 Benefit Processing in PFMS Live 27/03/2022
Displaying 1321 - 1350 of 1581